CEOs talk talent
Attracting and retaining a steady supply of top talent is tough to master. In this session, four CEOs each take on a talent topic they feel makes the biggest impact on their teams to impart actionable guidance in areas such as recruiting, flexibility, rewards, training and leadership.
EY Americas Vice Chair - Talent
As an EY Americas Vice Chair, Talent, Kelly focuses her efforts on creating an exceptional experience for the 54,000 people employed by EY member firms in the Americas by attracting top talent and increasing the engagement and retention of our people. Kelly’s career has spanned 23 years. She’s served primarily Fortune 500 companies, including a Fortune 50 company in Switzerland, for which she was the coordinating partner at Ernst & Young LLP overseeing its audit engagements. Prior to her current role, Kelly served as the Ernst & Young LLP Chicago Office Managing Partner and Coordinating and Senior Advisory Partner for Chicago’s largest clients. She was elected to the EY Americas Advisory Council and EY Global Advisory Council and is now a member of the EY Americas Operating Executive and the EY Global Talent Executive Committee. Kelly has been recognized by the World Economic Forum, the Anti-Defamation League and the Illinois CPA Society. She was awarded the US firm’s prestigious Rosemarie Meschi Award for her dedication to the development of its professionals.
Sallie Krawcheck is Chair of Ellevate Network and Ellevate Asset Management. In 2013, the former CEO of Smith Barney, Merrill Lynch and US Trust purchased the professional women’s network, previously known as 85 Broads. Sallie has been one of the most influential executives in financial services. For her integrity and independence of thought, Fortune magazine called her “The Last Honest Analyst.” She recently made Fast Company’s list of the 100 Most Creative People in 2014. As a LinkedIn Influencer, Sallie has more than 620,000 followers and nearly 25,000 Twitter followers. A rabid University of North Carolina Tar Heels fan, Sallie spends time advising start-ups and focusing on education-oriented philanthropy.
Chairman and CEO
Michael A. Mussallem has been Chairman and Chief Executive Officer of Edwards Lifesciences since 2000 when the company spun off from Baxter International. Mussallem held a variety of positions at Baxter from 1979 until 2000 with increasing responsibility in engineering, product development and general management. Mussallem serves on the boards and executive committees of the Advanced Medical Technology Association (AdvaMed) and the Healthcare Leadership Council. He is an advisory board member for the Leonard D. Schaeffer Center for Health Policy & Economics at the University of Southern California and a trustee of the UC Irvine Foundation. Mussallem received a bachelor’s degree in Chemical Engineering and an honorary doctorate degree from the Rose-Hulman Institute of Technology.
President & CEO
Paul Segre is the President and Chief Executive Officer at Genesys. Since taking on this position in 2007, he has led the company to consistent yearly double-digit growth, including record revenues of more than $610 million in 2012. Paul joined Genesys in 2002 as Chief Technology Officer with responsibility for product management and engineering. From 2002 to 2011, Paul held a variety of executive management roles at Alcatel-Lucent, including President of the Applications Group, which included Genesys. He holds a bachelor's degree in Mathematics and a master's degree in Operations Research from Stanford University.